Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amphenol
APH
|
+$1.61B |
| 2 |
Progressive
PGR
|
+$1.49B |
| 3 |
CGHM
Capital Group Municipal High-Income ETF
CGHM
|
+$1.44B |
| 4 |
Accenture
ACN
|
+$1.3B |
| 5 |
Gartner
IT
|
+$910M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.58B |
| 2 |
GE Vernova
GEV
|
+$1.45B |
| 3 |
Broadcom
AVGO
|
+$1.45B |
| 4 |
VICI Properties
VICI
|
+$1.39B |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$1.29B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.8% |
| 2 | Industrials | 12.85% |
| 3 | Financials | 12.29% |
| 4 | Communication Services | 10.98% |
| 5 | Consumer Discretionary | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Gerdau
GGB
$9.42B
| $96.2M | 0.02% |
31,046,243
+581,958
| +2% | +$1.76M |
|
302
AB InBev
BUD
$158B
| $95.7M | 0.02% |
1,598,808
+1,891
| +0.1% | +$119K |
|
303
HEICO Corp Class A
HEI.A
$38.1B
| $95.6M | 0.02% |
377,054
-18,155
| -5% | -$4.54M |
|
304
Estee Lauder
EL
$31.6B
| $94.8M | 0.02% |
1,075,428
+9,227
| +0.9% | +$822K |
|
305
Mineralys Therapeutics
MLYS
$2.31B
| $90.8M | 0.01% |
2,393,396
-505,624
| -17% | -$10.9M |
|
306
FMC
FMC
$1.27B
| $89.4M | 0.01% |
2,659,372
+1,426,667
| +116% | +$55.7M |
|
|
BWIN
307
Baldwin Insurance Group
BWIN
$2.99B
| $88.7M | 0.01% |
3,145,429
| – | – |
|
308
Ceco Environmental
CECO
$4.5B
| $85.8M | 0.01% |
1,675,351
-295,983
| -15% | -$12.5M |
|
309
Glacier Bancorp
GBCI
$6.48B
| $84.8M | 0.01% |
1,742,780
+254,514
| +17% | +$11.9M |
|
310
Cadre Holdings
CDRE
$1.45B
| $84.7M | 0.01% |
2,320,341
| – | – |
|
311
Intel
INTC
$527B
| $81.3M | 0.01% |
+2,423,251
| New | +$58.7M |
|
312
Wingstop
WING
$3.1B
| $79.5M | 0.01% |
315,706
| – | – |
|
313
Four Corners Property Trust
FCPT
$2.76B
| $79.2M | 0.01% |
3,246,154
| – | – |
|
314
Ametek
AME
$58.7B
| $76.9M | 0.01% |
409,855
+14,823
| +4% | +$2.73M |
|
315
General Mills
GIS
$20.8B
| $76.2M | 0.01% |
1,511,694
-468,119
| -24% | -$23.5M |
|
316
Veeva Systems
VEEV
$41B
| $75.8M | 0.01% |
254,419
-86,832
| -25% | -$24.4M |
|
317
Crown Castle
CCI
$32.2B
| $75.5M | 0.01% |
+782,096
| New | +$79.2M |
|
318
Phreesia
PHR
$780M
| $73.7M | 0.01% |
3,134,872
| – | – |
|
319
Cactus
WHD
$5.78B
| $72.8M | 0.01% |
1,845,521
+52,139
| +3% | +$2.19M |
|
320
TransUnion
TRU
$15.5B
| $70.2M | 0.01% |
837,705
-404,945
| -33% | -$36.8M |
|
|
APO.PRA
321
DELISTED
Apollo Global Management Series A
APO.PRA
| $68.2M | 0.01% |
970,400
| – | – |
|
|
TLN
322
Talen Energy Corp
TLN
$17.2B
| $68M | 0.01% |
159,856
+13
| +0% | +$4.7K |
|
323
Cytokinetics
CYTK
$10.2B
| $64.8M | 0.01% |
1,178,780
+10,670
| +0.9% | +$440K |
|
324
iShares MSCI EAFE ETF
EFA
$80.3B
| $64.2M | 0.01% |
690,803
+434,866
| +170% | +$39.5M |
|
325
Astronics
ATRO
$4.57B
| $64.2M | 0.01% |
+1,688,400
| New | +$51.4M |
|
Similar funds
Capital International Investors's Q3 2025 Portfolio in Review
As of Q3 2025, Capital International Investors held 472 positions worth $619B, up 6.7% from $581B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Capital International Investors's Q3 2025 filing shows 29 new, 218 increased, 160 reduced and 24 closed positions. Its largest new stake was Gartner: 3,119,843 shares worth $820M. The largest sale was Bristol-Myers Squibb, an estimated $1.58B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Industrials and Financials.
- Capital International Investors's largest Q3 2025 buy was Gartner: 3,119,843 shares worth $820M.
- Capital International Investors added most to Amphenol in Q3 2025, an estimated $1.61B increase.
- Capital International Investors's biggest Q3 2025 reduction was Bristol-Myers Squibb, cutting an estimated $1.58B.
- Capital International Investors fully exited Eaton in Q3 2025, selling an estimated $607M.
- Capital International Investors's ten largest holdings make up 35% of its $619B portfolio in Q3 2025.
- Capital International Investors opened 29 new positions and closed 24 in Q3 2025.
- Capital International Investors's portfolio value rose 6.7% quarter-over-quarter to $619B.
Based on Capital International Investors's 13F filing for Q3 2025, filed 13 Nov 2025.